Oral fumarate for relapsing-remitting multiple sclerosis.
Sorensen
Per Soelberg
PS
Danish Multiple Sclerosis Research Center, Department of Neurology, Rigshospitalet, DK-2100, Copenhagen, Denmark. pss@rh.dk
Sellebjerg
Finn
F
D000284:Administration, Oral; D000069462:Dimethyl Fumarate; D004305:Dose-Response Relationship, Drug; D005650:Fumarates / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy*
D005650:Fumarates; D007166:Immunosuppressive Agents; D000069462:Dimethyl Fumarate